- 5 Résultats
prix le plus bas: € 31,98, prix le plus élevé: € 312,90, prix moyen: € 193,22
1
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - Ali M. Emran
Commander
sur ZVAB.com
€ 203,61
Envoi: € 0,001
CommanderLien sponsorisé
Ali M. Emran:

New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - edition reliée, livre de poche

1992, ISBN: 0306440350

[EAN: 9780306440359], Neubuch, [SC: 0.0], [PU: Springer US], CANCER; CHEMISTRY; COMPUTER; IMAGING; NUCLEARMEDICINE; POSITRONEMISSIONTOMOGRAPHY(PET); RADIOLOGY; RESEARCH; ULTRASONOGRAPHY, … Plus…

NEW BOOK. Frais d'envoiVersandkostenfrei. (EUR 0.00) AHA-BUCH GmbH, Einbeck, Germany [51283250] [Rating: 5 (von 5)]
2
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - Ali M. Emran
Commander
sur AbeBooks.de
€ 203,61
Envoi: € 0,001
CommanderLien sponsorisé

Ali M. Emran:

New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - edition reliée, livre de poche

1992, ISBN: 0306440350

[EAN: 9780306440359], Neubuch, [PU: Springer US], CANCER; CHEMISTRY; COMPUTER; IMAGING; NUCLEARMEDICINE; POSITRONEMISSIONTOMOGRAPHY(PET); RADIOLOGY; RESEARCH; ULTRASONOGRAPHY, Druck auf A… Plus…

NEW BOOK. Frais d'envoiVersandkostenfrei. (EUR 0.00) AHA-BUCH GmbH, Einbeck, Germany [51283250] [Rating: 5 (von 5)]
3
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control
Commander
sur Springer.com
€ 213,99
Envoi: € 0,001
CommanderLien sponsorisé
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - nouveau livre

ISBN: 9780306440359

Marking the 200th National Meeting of the American Chemical Society, The Division of Nuclear Chemistry and Technology hosted a group of about 90 scientists from 15 different countries to … Plus…

Nr. 978-0-306-44035-9. Frais d'envoiWorldwide free shipping, , DE. (EUR 0.00)
4
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control
Commander
sur amazon.de
€ 31,98
Envoi: € 3,001
CommanderLien sponsorisé
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - edition reliée, livre de poche

1992, ISBN: 9780306440359

Springer, Gebundene Ausgabe, Auflage: 1991, 531 Seiten, Publiziert: 1992-01-31T00:00:01Z, Produktgruppe: Buch, 5.97 kg, Pharmakologie, Medizin, Kategorien, Bücher, Sonografie, Nuklearmedi… Plus…

Gut Frais d'envoiAuf Lager. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 3.00) Phatpocket Bücher
5
Commander
sur AbeBooks.de
€ 312,90
Envoi: € 8,021
CommanderLien sponsorisé
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - edition reliée, livre de poche

1992, ISBN: 0306440350

[EAN: 9780306440359], Neubuch, [PU: Springer], pp. 536, Books

NEW BOOK. Frais d'envoi EUR 8.02 Books Puddle, New York, NY, U.S.A. [70780988] [Rating: 4 (von 5)]

1Comme certaines plateformes ne transmettent pas les conditions d'expédition et que celles-ci peuvent dépendre du pays de livraison, du prix d'achat, du poids et de la taille de l'article, d'une éventuelle adhésion de la plateforme, d'une livraison directe par la plateforme ou via un prestataire tiers (Marketplace), etc. il est possible que les frais de livraison indiqués par eurolivre ne correspondent pas à ceux de la plateforme qui propose l'article.

Données bibliographiques du meilleur livre correspondant

Détails sur le livre

Informations détaillées sur le livre - New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control


EAN (ISBN-13): 9780306440359
ISBN (ISBN-10): 0306440350
Version reliée
Livre de poche
Date de parution: 1992
Editeur: Emran, Ali M. Springer
536 Pages
Poids: 1,189 kg
Langue: eng/Englisch

Livre dans la base de données depuis 2007-11-01T22:08:51+01:00 (Paris)
Page de détail modifiée en dernier sur 2024-01-31T20:39:43+01:00 (Paris)
ISBN/EAN: 9780306440359

ISBN - Autres types d'écriture:
0-306-44035-0, 978-0-306-44035-9
Autres types d'écriture et termes associés:
Auteur du livre: ali, roy thomas, thomas anderson, roy james, international group control, fowler james, robert peterson, robert brien, james houston, joseph peterson, harold james
Titre du livre: new trends radiopharmaceutical synthesis quality assurance regulatory control, out control


Données de l'éditeur

Auteur: Ali M. Emran
Titre: New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control
Editeur: Springer; Springer US
520 Pages
Date de parution: 1992-01-31
New York; NY; US
Langue: Anglais
213,99 € (DE)
219,99 € (AT)
236,00 CHF (CH)
Available
XI, 520 p.

BB; Hardcover, Softcover / Medizin/Pharmazie; Pharmakologie; Verstehen; cancer; chemistry; computer; imaging; nuclear medicine; positron emission tomography (PET); radiology; research; Ultrasonography; Pharmacology; Nuclear Medicine; Ultrasonics; Organic Chemistry; Nuklearmedizin; Akustik und Tontechnik; Organische Chemie; EA; BC

1.1 Introductory Remarks.- 1.2 Overview.- 1.3 A Muscarinic Receptor Ligand: Review of the Chemistry and Applications.- 2.1 Aspects on the Synthesis and Design of 11C-Tracers for PET.- 2.2 Special Problems Associated with the Synthesis of High Specific Activity Carbon-11 Labeled Radiotracers.- 2.3 PET Radiopharmaceuticals via Reductive Carboxylation.- 2.4 [13N] Labeled Tracers, Synthesis and Applications.- 2.5 Cu1+ Assisted Nucleophilic Exchange Radiohalogenation: Application and Mechanistic Approach.- 2.6 Potential Breast Tumor Imaging Agents: Fluorotamoxifen and Derivatives.- 2.7 Fluorinated Azabicycloesters as Muscarinic Receptor Ligands for Application with PET.- 2.8 Flourine-18 Ligands for the In Vivo Study of ?-Adrenergic Receptors in the Heart and Lung.- 2.9 Design and Radiofluorination of Benzamide Dopamine D2 Receptor Ligands.- 3.1 A Synthetic Porphyrin with High Affinity for Lung Cancer Cells and Inflamed Lymphatic Tissue.- 3.2 Galium and Copper Radiopharmaceutical Chemistry.- 3.3 Radiometallating Antibodies and Autoantigenic Peptides.- 3.4 Biomedical Use of Arsenic Radioisotopes.- 3.5 Improved Extraction Efficiency of Gallium-67 After Irradiation of Zinc-68 with Protons.- 3.6 Chemistry and Concept for An Automated 72Se/72As Generator.- 3.7 Radiochemistry of Monoclonal Antibody Labeling.- 3.8 The Study on the Formulation of A Tc(V)-99m-DMS Lyophilized Instant Kit for Tumor Scintigraphy.- 3.9 A National Biomedical Tracer Facility.- 3.10 Tantalum-178-Labeled Radiopharmaceutical Synthesis Via The Intermediate Tantalum Pentachloride — A Potential Myocardial Perfusion Agent.- 3.11 Status of Lead and Bismuth for Radioimmunoimaging and Therapy.- 4.1 Use of Organolithium and Organomagnesium Reagents In Radiopharmaceutical Synthesis.- 4.2 Application of OrganosiliconChemistry to the Synthesis of Gamma and Positron Emitting Radiotracers for Use In Nuclear Imaging Studies.- 4.3 The Synthesis of Halogenated Radiopharmaceuticals using Organomercurials.- 4.4 Synthesis of Radiopharmaceuticals Via Organoboranes.- 4.5 Radiosotope Incorporation via Aryl and Alkenyl Trialkyltin Intermediates.- 5.1 Robots In the Radiopharmaceutical Laboratory: Will They Replace the Chemist?.- 5.2 The Use of Transducers for Automated Radiopharmaceutical Synthesis Procedures.- 5.3 Facilitating the Design and Operation of Computer-Controlled Radiochemistry Synthesizers with an “Electronic Toolbox”.- 5.4 Knowledge-Based Automated Radiopharmaceutical Manufacturing for Positron Emission Tomography.- 5.5 Robotic Thin Layer Chromatography Instrument for Synthetic Chemistry.- 5.6 Automated Radiochemical Processing for Clinical PET.- 5.7 Captive Solvent Methods for Fast, Simple, Carbon-11 Radioalkylation.- 6.1 Identity, Strength, Purity, Quality and Safety: Common Goals for New Drugs.- 6.2 Quality Assurance Considerations Related to “In-House” Radiopharmaceutical Preparations Utilizing Positron Emitting Radionuclides.- 6.3 The Role of High Performance Liquid Chromatography In Radiochemical/Radiopharmaceutical Synthesis and Quality Assurance.- 6.4 Experience from a National Quality Assurance System on Radiopharmaceuticals.- 6.5 Radiopharmaceutical Production for PET: Quality Assurance Practice, Experience and Issues.- 6.6 Post-Column Reactor Determination of Aluminum Concentration in Cyclotron Produced Radiorubidium.- 6.7 Implications of the Food, Drug and Cosmetic Act on the Quality Assurance of Radiopharmaceuticals used in the United States.- 6.8 Quality Assurance in Radiochemical/Radiopharmaceutical Manufacturing.- 7.1 Regulatory Control ofRadiopharmaceutics.- 7.2 Regulatory Control of Radiopharmaceuticals.- 7.3 Development of European Regulations on Radiopharmaceuticals.- 7.4 Regulation of Cyclotron Radiopharmaceutical Production and Distribution: An Agreement State Perspective.- 7.5 New Drug Approval Process for Radiopharmaceuticals.- 7.6 Abbreviated New Drug Applications (ANDAS): Future Trends in Radiopharmaceuticals.

< pour archiver...